Collaboration Advances DNA-delivered Antibodies to Prevent COVID-19
PHILADELPHIA — (July 7, 2022) — Under a Defense Advanced Research Projects Agency ( DARPA ) and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense ( JPEO - CBRND ) funded program, a novel COVID -19 antibody delivery approach has advanced to clinical trials.